Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
2000 2
2001 7
2002 3
2003 4
2004 5
2005 2
2006 4
2007 3
2008 2
2009 2
2010 2
2011 5
2012 6
2013 7
2014 2
2015 3
2016 5
2017 4
2018 2
2019 4
2020 1
2021 5
2022 5
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, Jain SS, Michalik DE, Sharma K, Truong DT, Wood JB, Kim KK, Jain S; KIDCARE Multicenter Study Group. Burns JC, et al. Lancet Child Adolesc Health. 2021 Dec;5(12):852-861. doi: 10.1016/S2352-4642(21)00270-4. Epub 2021 Oct 27. Lancet Child Adolesc Health. 2021. PMID: 34715057 Free article. Clinical Trial.
Multicenter prospective observational study of fungal keratitis in Japan: analyses of culture-positive cases.
Inoue Y, Ohashi Y, Shimomura Y, Sotozono C, Hatano H, Fukuda M, Eguchi H, Araki-Sasaki K, Suzuki T, Hoshi S, Asari S, Sunada A, Kimura K, Yaguchi T, Makimura K; Multicenter Study Group of Fungal Keratitis in Japan. Inoue Y, et al. Jpn J Ophthalmol. 2022 May;66(3):227-239. doi: 10.1007/s10384-022-00904-5. Epub 2022 Mar 29. Jpn J Ophthalmol. 2022. PMID: 35348982
CYP19A1 mediates severe SARS-CoV-2 disease outcome in males.
Stanelle-Bertram S, Beck S, Mounogou NK, Schaumburg B, Stoll F, Al Jawazneh A, Schmal Z, Bai T, Zickler M, Beythien G, Becker K, de la Roi M, Heinrich F, Schulz C, Sauter M, Krasemann S, Lange P, Heinemann A, van Riel D, Leijten L, Bauer L, van den Bosch TPP, Lopuhaä B, Busche T, Wibberg D, Schaudien D, Goldmann T, Lüttjohann A, Ruschinski J, Jania H, Müller Z, Pinho Dos Reis V, Krupp-Buzimkic V, Wolff M, Fallerini C, Baldassarri M, Furini S, Norwood K, Käufer C, Schützenmeister N, von Köckritz-Blickwede M, Schroeder M, Jarczak D, Nierhaus A, Welte T, Kluge S, McHardy AC, Sommer F, Kalinowski J, Krauss-Etschmann S, Richter F, von der Thüsen J, Baumgärtner W, Klingel K, Ondruschka B; GEN-COVID Multicenter Study Group; Renieri A, Gabriel G. Stanelle-Bertram S, et al. Cell Rep Med. 2023 Sep 19;4(9):101152. doi: 10.1016/j.xcrm.2023.101152. Epub 2023 Aug 12. Cell Rep Med. 2023. PMID: 37572667 Free PMC article.
Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs.
Kimura K, Inoue Y, Asari S, Sunada A, Ohashi Y, Shimomura Y, Sotozono C, Hatano H, Fukuda M, Eguchi H, Araki-Sasaki K, Suzuki T, Hoshi S, Tobe T, Yaguchi T, Makimura K; Multicenter Study Group of Fungal Keratitis in Japan. Kimura K, et al. Jpn J Ophthalmol. 2022 May;66(3):240-253. doi: 10.1007/s10384-022-00907-2. Epub 2022 Mar 29. Jpn J Ophthalmol. 2022. PMID: 35348983
The found down patient: A Western Trauma Association multicenter study.
Howard BM, Kornblith LZ, Conroy AS, Burlew CC, Wagenaar AE, Chouliaras K, Hill JR, Carrick MM, Mallory GR, Watkins JR, Truitt MS, Ciesla DJ, Davis JA, Vail CJ, Kemp Bohan PM, Nelson MF, Callcut RA, Cohen MJ; Western Trauma Association Multicenter Study Group. Howard BM, et al. J Trauma Acute Care Surg. 2015 Dec;79(6):976-82; discussion 982. doi: 10.1097/TA.0000000000000862. J Trauma Acute Care Surg. 2015. PMID: 26488323 Free PMC article.
HLA-DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID-19.
Farias TDJ, Brugiapaglia S, Croci S, Magistroni P, Curcio C, Zguro K, Fallerini C, Fava F, Pettini F, Kichula KM, Pollock NR, Font-Porterias N, Palmer WH, Marin WM, Baldassarri M, Bruttini M, Hollenbach JA, Hendricks AE, Meloni I, Novelli F; GEN-COVID Multicenter Study Group; Renieri A, Furini S, Norman PJ, Amoroso A. Farias TDJ, et al. HLA. 2024 Jan;103(1):e15251. doi: 10.1111/tan.15251. Epub 2023 Oct 18. HLA. 2024. PMID: 37850268 Free article.
81 results